WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) recently awarded restricted stock units (RSUs) totaling 20,334 shares of common stock to 24 newly hired employees. These awards were granted as part of the company’s 2024 Inducement Stock Incentive Plan to attract key talent and were approved by the board’s compensation committee in accordance with Nasdaq Listing Rule 5635(c)(4).
The RSUs, effective April 1, 2025, will vest incrementally, with 25% of the shares becoming available on each of the first four anniversaries of the grant date, contingent on the employees’ continued service with the company.
Looking ahead, the company remains focused on driving innovation while strengthening its team to meet evolving industry demands.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.